Triumeq 600-50-300 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FCK1F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,252
Award facts
- Contract value 100% obligated
- $49,251.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units, with a contract ceiling value of $49.3K. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which is also designated as the place of performance—is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999B through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. TRIUMEQ is an antiretroviral medication used in HIV treatment, reflecting the company's role in delivering specialized therapeutic agents across multiple domains to support Department of Defense and other federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FCK1F?
SPE2DR26FCK1F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FCK1F worth?
The government has obligated $49,252 on SPE2DR26FCK1F.
Is contract SPE2DR26FCK1F an order under another contract?
Yes. SPE2DR26FCK1F is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCK1F competed?
The extent of competition for SPE2DR26FCK1F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award